vs
GLOBUS MEDICAL INC（GMED）与ROKU, INC（ROKU）财务数据对比。点击上方公司名可切换其他公司
ROKU, INC的季度营收约是GLOBUS MEDICAL INC的1.5倍（$1.2B vs $826.4M），GLOBUS MEDICAL INC净利率更高（17.0% vs -2.2%，领先19.2%），GLOBUS MEDICAL INC同比增速更快（25.7% vs -18.3%），ROKU, INC自由现金流更多（$298.4M vs $202.4M），过去两年GLOBUS MEDICAL INC的营收复合增速更高（16.7% vs 13.6%）
Globus Medical是总部位于美国宾夕法尼亚州奥杜邦的上市骨科医疗器械企业，专注于相关产品的设计、研发与商业化，助力外科医生为肌肉骨骼系统疾病患者提供治疗方案，促进患者康复。
Roku是美国流媒体技术企业，2002年由安东尼·伍德创立，主营数字媒体播放器、电视硬件生产，流媒体内容分发及平台广告运营。截至2024年覆盖用户达1.45亿，是美国流媒体视频分发领域的市场领导者，业务覆盖澳、加、法、德、英及拉美多国。
GMED vs ROKU — 直观对比
营收规模更大
ROKU
是对方的1.5倍
$826.4M
营收增速更快
GMED
高出44.0%
-18.3%
净利率更高
GMED
高出19.2%
-2.2%
自由现金流更多
ROKU
多$96.0M
$202.4M
两年增速更快
GMED
近两年复合增速
13.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $826.4M | $1.2B |
| 净利润 | $140.6M | $-27.4M |
| 毛利率 | 68.4% | 35.6% |
| 营业利润率 | 20.5% | 59.7% |
| 净利率 | 17.0% | -2.2% |
| 营收同比 | 25.7% | -18.3% |
| 净利润同比 | 430.4% | -361.0% |
| 每股收益（稀释后） | $1.01 | $0.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GMEDROKU
| Q1 26 | — | $1.2B | ||
| Q4 25 | $826.4M | $1.4B | ||
| Q3 25 | $769.0M | $1.2B | ||
| Q2 25 | $745.3M | $1.1B | ||
| Q1 25 | $598.1M | $1.0B | ||
| Q4 24 | $657.3M | $1.2B | ||
| Q3 24 | $625.7M | $1.1B | ||
| Q2 24 | $629.7M | $968.2M |
净利润GMEDROKU
| Q1 26 | — | $-27.4M | ||
| Q4 25 | $140.6M | $80.5M | ||
| Q3 25 | $119.0M | $24.8M | ||
| Q2 25 | $202.8M | $10.5M | ||
| Q1 25 | $75.5M | $-27.4M | ||
| Q4 24 | $26.5M | $-35.5M | ||
| Q3 24 | $51.8M | $-9.0M | ||
| Q2 24 | $31.8M | $-34.0M |
毛利率GMEDROKU
| Q1 26 | — | 35.6% | ||
| Q4 25 | 68.4% | 43.5% | ||
| Q3 25 | 67.2% | 43.4% | ||
| Q2 25 | 66.6% | 44.8% | ||
| Q1 25 | 67.3% | 43.6% | ||
| Q4 24 | 59.9% | 42.7% | ||
| Q3 24 | 56.8% | 45.2% | ||
| Q2 24 | 58.7% | 43.9% |
营业利润率GMEDROKU
| Q1 26 | — | 59.7% | ||
| Q4 25 | 20.5% | 4.7% | ||
| Q3 25 | 17.9% | 0.8% | ||
| Q2 25 | 10.2% | -2.1% | ||
| Q1 25 | 16.2% | -5.7% | ||
| Q4 24 | 9.2% | -3.3% | ||
| Q3 24 | 7.7% | -3.4% | ||
| Q2 24 | 7.9% | -7.4% |
净利率GMEDROKU
| Q1 26 | — | -2.2% | ||
| Q4 25 | 17.0% | 5.8% | ||
| Q3 25 | 15.5% | 2.0% | ||
| Q2 25 | 27.2% | 0.9% | ||
| Q1 25 | 12.6% | -2.7% | ||
| Q4 24 | 4.0% | -3.0% | ||
| Q3 24 | 8.3% | -0.9% | ||
| Q2 24 | 5.0% | -3.5% |
每股收益（稀释后）GMEDROKU
| Q1 26 | — | $0.57 | ||
| Q4 25 | $1.01 | $0.55 | ||
| Q3 25 | $0.88 | $0.16 | ||
| Q2 25 | $1.49 | $0.07 | ||
| Q1 25 | $0.54 | $-0.19 | ||
| Q4 24 | $0.19 | $-0.24 | ||
| Q3 24 | $0.38 | $-0.06 | ||
| Q2 24 | $0.23 | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $557.2M | $2.4B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.6B | $2.7B |
| 总资产 | $5.3B | $4.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GMEDROKU
| Q1 26 | — | $2.4B | ||
| Q4 25 | $557.2M | $2.3B | ||
| Q3 25 | $18.8M | $2.3B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | $890.1M | $2.2B | ||
| Q3 24 | $71.9M | $2.1B | ||
| Q2 24 | $82.5M | $2.1B |
股东权益GMEDROKU
| Q1 26 | — | $2.7B | ||
| Q4 25 | $4.6B | $2.7B | ||
| Q3 25 | $4.4B | $2.6B | ||
| Q2 25 | $4.3B | $2.6B | ||
| Q1 25 | $4.1B | $2.5B | ||
| Q4 24 | $4.2B | $2.5B | ||
| Q3 24 | $4.1B | $2.5B | ||
| Q2 24 | $4.0B | $2.4B |
总资产GMEDROKU
| Q1 26 | — | $4.4B | ||
| Q4 25 | $5.3B | $4.4B | ||
| Q3 25 | $5.1B | $4.4B | ||
| Q2 25 | $5.0B | $4.3B | ||
| Q1 25 | $4.7B | $4.2B | ||
| Q4 24 | $5.3B | $4.3B | ||
| Q3 24 | $5.1B | $4.3B | ||
| Q2 24 | $5.0B | $4.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $248.6M | $199.1M |
| 自由现金流经营现金流 - 资本支出 | $202.4M | $298.4M |
| 自由现金流率自由现金流/营收 | 24.5% | 23.9% |
| 资本支出强度资本支出/营收 | 5.6% | — |
| 现金转化率经营现金流/净利润 | 1.77× | — |
| 过去12个月自由现金流最近4个季度 | $588.8M | $640.0M |
8季度趋势，按日历期对齐
经营现金流GMEDROKU
| Q1 26 | — | $199.1M | ||
| Q4 25 | $248.6M | $107.7M | ||
| Q3 25 | $249.7M | $127.6M | ||
| Q2 25 | $77.9M | $109.7M | ||
| Q1 25 | $177.3M | $138.7M | ||
| Q4 24 | $210.3M | $79.3M | ||
| Q3 24 | $203.7M | $68.7M | ||
| Q2 24 | $54.3M | $23.4M |
自由现金流GMEDROKU
| Q1 26 | — | $298.4M | ||
| Q4 25 | $202.4M | $106.6M | ||
| Q3 25 | $213.9M | $126.5M | ||
| Q2 25 | $31.3M | $108.6M | ||
| Q1 25 | $141.2M | $136.8M | ||
| Q4 24 | $193.2M | $76.8M | ||
| Q3 24 | $161.7M | $67.6M | ||
| Q2 24 | $26.5M | $22.5M |
自由现金流率GMEDROKU
| Q1 26 | — | 23.9% | ||
| Q4 25 | 24.5% | 7.6% | ||
| Q3 25 | 27.8% | 10.4% | ||
| Q2 25 | 4.2% | 9.8% | ||
| Q1 25 | 23.6% | 13.4% | ||
| Q4 24 | 29.4% | 6.4% | ||
| Q3 24 | 25.8% | 6.4% | ||
| Q2 24 | 4.2% | 2.3% |
资本支出强度GMEDROKU
| Q1 26 | — | — | ||
| Q4 25 | 5.6% | 0.1% | ||
| Q3 25 | 4.7% | 0.1% | ||
| Q2 25 | 6.2% | 0.1% | ||
| Q1 25 | 6.0% | 0.2% | ||
| Q4 24 | 2.6% | 0.2% | ||
| Q3 24 | 6.7% | 0.1% | ||
| Q2 24 | 4.4% | 0.1% |
现金转化率GMEDROKU
| Q1 26 | — | — | ||
| Q4 25 | 1.77× | 1.34× | ||
| Q3 25 | 2.10× | 5.14× | ||
| Q2 25 | 0.38× | 10.45× | ||
| Q1 25 | 2.35× | — | ||
| Q4 24 | 7.94× | — | ||
| Q3 24 | 3.93× | — | ||
| Q2 24 | 1.71× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GMED
| Other | $391.8M | 47% |
| Nevro Merger Agreement | $293.6M | 36% |
| Enabling Technologies | $141.0M | 17% |
ROKU
| Advertising | $612.7M | 49% |
| Subscriptions | $518.5M | 42% |
| Devices | $117.6M | 9% |
